K. Katsu

发表

Comparative in-vitro activities of newer cephalosporins cefclidin, cefepime, and cefpirome against ceftazidime- or imipenem-resistant Pseudomonas aeruginosa.

N. Watanabe, R. Hiruma, K. Katsu, 1992, The Journal of antimicrobial chemotherapy.

E-0702, a new cephalosporin, is incorporated into Escherichia coli cells via the tonB-dependent iron transport system

T. Nagasu, K. Kitoh, N. Watanabe, 1987, Antimicrobial Agents and Chemotherapy.

In vitro antibacterial activity of E-0702, a new semisynthetic cephalosporin

S. Mitsuhashi, K. Kitoh, M. Inoue, 1982, Antimicrobial Agents and Chemotherapy.

Prophylactic activity of dihydro-heptaprenol, a synthetic polyprenol derivative, against Sendai virus infection in mice

J. Iida, I. Azuma, K. Tsukidate, 1990 .

In vitro and in vivo antibacterial activities of ER-35786, a new antipseudomonal carbapenem

N. Watanabe, F. Ohba, K. Katsu, 1997, Antimicrobial agents and chemotherapy.

In vitro and in vivo antifungal activities of ER-30346, a novel oral triazole with a broad antifungal spectrum

T. Nakamura, K. Katsu, K. Hata, 1996, Antimicrobial agents and chemotherapy.

Efficacy of ER-30346, a novel oral triazole antifungal agent, in experimental models of aspergillosis, candidiasis, and cryptococcosis

K. Katsu, K. Hata, T. Toyosawa, 1996, Antimicrobial agents and chemotherapy.

Bactericidal activity of cefclidin (E1040) against Pseudomonas aeruginosa under conditions simulating plasma pharmacokinetics: lack of development of chromosomally-mediated resistance to beta-lactams.

N. Watanabe, K. Katsu, 1992, The Journal of antimicrobial chemotherapy.

Cefclidin (E1040), a novel cephalosporin: lack of selection of beta-lactamase overproducing mutants in an in vitro pharmacokinetic model system.

N. Watanabe, K. Katsu, 1992, The Journal of antibiotics.

In vitro evaluation of E1077, a new cephalosporin with a broad antibacterial spectrum

N. Watanabe, R. Hiruma, K. Katsu, 1992, Antimicrobial Agents and Chemotherapy.

In vitro evaluation of E1040, a new cephalosporin with potent antipseudomonal activity

K. Kitoh, N. Watanabe, K. Katsu, 1988, Antimicrobial Agents and Chemotherapy.

Transposition of the carbenicillin-hydrolyzing beta-lactamase gene

S. Mitsuhashi, M. Inoue, K. Katsu, 1982, Journal of bacteriology.

Studies on orally active cephalosporins. II. Synthesis and structure-activity relations of new [(E) or (Z) 3-substituted carbamoyloxy]-1-propenyl cephalosporins.

A. Tsuruoka, I. Tsukada, R. Hiruma, 1994, The Journal of antibiotics.

Studies on orally active cephalosporins. I. Synthesis and structure-activity relationships of new 3-substituted carbamoyloxymethyl cephalosporins.

A. Tsuruoka, I. Tsukada, R. Hiruma, 1994, Journal of antibiotics (Tokyo. 1968).

Studies on Orally Active Cephalosporins. Part 2. Synthesis and Structure-Activity Relations of New ((E) or (Z) 3-Substituted Carbamoyloxy)-1-propenylcephalosporins.

Yuuki Komatsu, A. Tsuruoka, I. Tsukada, 1995 .

Studies on Orally Active Cephalosporins. Part 1. Synthesis and Structure-Activity Relationships of New 3-Substituted Carbamoyloxymethyl Cephalosporins.

Yuuki Komatsu, A. Tsuruoka, I. Tsukada, 1995 .

Plasmid-mediated carbencillin hydrolyzing beta-lactamases of Proteus mirabilis.

S. Mitsuhashi, M. Inoue, K. Katsu, 1981, The Journal of antibiotics.

In vitro activity of E1040 against imipenem-resistant Pseudomonas aeruginosa strains

S. Iyobe, K. Katsu, E. Inoue, 1992, Antimicrobial Agents and Chemotherapy.

Affinity of E1077, a new cephalosporin, for penicillin-binding proteins of Staphylococcus aureus and its antistaphylococcal activity.

N. Watanabe, K. Katsu, 1993, The Journal of antibiotics.

AFFINITY OF El077, A NEW CEPHALOSPORIN, FOR PENICILLIN-BINDING PROTEINS OF Staphylococcus aureus AND ITS ANTISTAPHYLOCOCCALACTIVITY

Watanabe, K. Katsu, Nao-aki, 2006 .